Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-08-02

FDA Approved: ERLEADA — Supplemental Application (Janssen Products, LP)

View source ↗

Summary

FDA approved a supplemental application for Erleada (apalutamide) submitted by Janssen Products, LP. The supplemental submission is related to changes to the ap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ERLEADA (apalutamide)

Snippet

SUPPL AP for ERLEADA (APALUTAMIDE)